We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
Consensus vs. actual, and revenue trend
| 분기 | 발표일 | 시각 | EPS 예상 | EPS 실제 | 서프라이즈 | 매출 예상 | 매출 실제 | 상태 |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 04. | 장 마감 후 (AMC) | $-0.14 | — | — | $15.42M | — | 예정 |
| FY2026 Q1 | 2025. 03. 31. | 시각 미정 | — | $1.23 | — | — | $11.78M | 보고됨 |
| FY2025 Q3 | 2024. 09. 30. | 시각 미정 | — | $-1.56 | — | — | $33.4M |
Consensus PT $11 · 2 analysts
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2025. 08. 06. | Leerink Partners | — | 투자의견 상향 | Market Perform → Outperform | — | Leerink Partners: Market Perform → Outperform |
| 2025. 01. 16. | Stephens & Co. | — | 의견 유지 | Overweight → Overweight | — | Stephens & Co.: Overweight |
동일 리서치펌의 과거 의견 변화, 동일 섹터 내 다른 종목 액션과 비교 가능
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
| FY2025 Q2 | 2024. 06. 30. | 시각 미정 | — | $-0.7 | — | — | $18.88M | 보고됨 |
Automated summary from public sources · not investment advice
공시·실적·기관 변화를 한국어 한 단락으로 요약. 원문 출처와 함께 제공됩니다.
Ranked by position value
| # | 기관 | 운용 형태 | 보유 주식 | 평가액 | 비중 | 변화율 | 포지션 |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 72,327 | $379.72M | 0.00% | — | 신규 편입 |
| 2 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 55,945 | $293.71M | 0.00% | — | 신규 편입 |
신규 편입·전량 매도·비중 변화까지 모두 확인할 수 있습니다.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
Stored first · Google News · Yahoo Finance (English)
Insider Sell: Christopher Brown Sells 30,000 Shares of 908 Devices Inc (MASS) - GuruFocus
Insider Sell: Christopher Brown Sells 30,000 Shares of 908 Devices Inc (MASS) GuruFocus
908 Devices director Christopher D. Brown sells $270,000 in stock - Investing.com UK
908 Devices director Christopher D. Brown sells $270,000 in stock Investing.com UK
908 Devices director Christopher D. Brown sells $270,000 in stock By Investing.com - Investing.com Australia
908 Devices director Christopher D. Brown sells $270,000 in stock By Investing.com Investing.com Australia
908 Devices director Christopher D. Brown sells $270,000 in stock By Investing.com - Investing.com Nigeria
908 Devices director Christopher D. Brown sells $270,000 in stock By Investing.com Investing.com Nigeria
908 Devices CFO Joseph H. Griffith IV sells $62,668 in stock - Investing.com
908 Devices CFO Joseph H. Griffith IV sells $62,668 in stock Investing.com
Awm investment sells $1.61m of 908 Devices stock By Investing.com - Investing.com Nigeria
Awm investment sells $1.61m of 908 Devices stock By Investing.com Investing.com Nigeria